Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.50
Bid: 140.00
Ask: 145.00
Change: 2.50 (1.79%)
Spread: 5.00 (3.571%)
Open: 142.50
High: 142.50
Low: 142.50
Prev. Close: 140.00
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

14 Mar 2023 13:49

RNS Number : 9513S
Manolete Partners PLC
14 March 2023
 

14 March 2023

 

Manolete Partners PLC

("Manolete" or the "Company")

 

Trading Update

Manolete Partners plc (AIM:MANO), the leading quoted UK insolvency litigation financing company, is pleased to provide the following update on trading for the year ending 31 March 2023 ("FY23").

 

Since the announcement of the Company's unaudited interim results in November 2022, trading has continued to rebound strongly. All figures below are subject to audit.

 

1. Record New Case Investments

 

As at the time of writing, the number of new case investments for FY23 year to date ("FY23 YTD") is 246, 55% higher than the 159 new case investments for the whole of FY22. The FY23 YTD number is already the highest Manolete has ever recorded.

 

As explained in the interim results, the first half of FY23 was still impacted by the UK Government's temporary suppression of UK insolvencies that only ended in March 2022, such that for H1 FY23 we recorded 83 new case investments (H1 FY22: 78). The record number for new case investments in FY23 is therefore overwhelmingly driven by the particularly strong performance in the second half of FY23: 163 new case investments, which is 96% higher than H1 FY23 and 101% higher than H2 FY22. Indeed, the 163 cases signed so far in H2 FY23 is more than the Company signed in the whole 12 months of FY22.

 

During its lifetime, Manolete has now invested in over 1,000 UK insolvency litigation claims, over 80% of which Manolete has purchased rather than funded. In more recent years, due to favourable legal changes, over 90% of cases have been purchased.

 

2. Record Case Completions

 

For the current FY23 YTD Manolete has already completed a record number of cases: 168 (FY22: 139 completed cases) representing an aggregate of £28.8m (FY22: £15.3m) comprising predominantly legally binding settlements plus a small number of favourable Court judgments. This record level of completed cases will drive cash income for the foreseeable future, as the Company collects in the cash owed by defendants on these matters.

 

3. Record Cash Recoveries

 

With two weeks to go until the year end, Manolete has delivered record gross cash recoveries from previously completed cases of £26.2m, 69% higher than the £15.5m for FY22. The £26.2m is spread across 227 separate completed cases (FY22: 183) at an average of £115k per case (FY22: £85k).

 

After all of the business's running costs (principally salaries and overheads) and after legal fees and the Insolvent Estate's share of our case recoveries, but before new case investments, taxation, dividends and interest, as at the end of February 2023 Manolete has generated £8.7m of net cash, representing a 179% increase compared to the comparable 11 month period for FY22 of £3.1m.

 

For the 11 months ended 28 February 2023, after all costs (including new case investments, taxation, dividends and interest), the Company generated £2.4m of net free cashflow compared to a net outflow of £5.1m for the comparable 11-month period for FY22.

 

4. The UK Bounce Back Loan ("BBL") Opportunity

 

As previously announced, the Company is working on a pilot with Barclays Bank to assist in the recovery of Bounce Back Loans that appear to have been misappropriated by a number of company directors. 119 companies were included in the Barclays pilot and, so far, 45 cases have been assigned to Manolete, in the early months of this calendar year. Of those 45 cases, Manolete has already settled three cases and has offers from Directors to settle on a further seven cases. In all but one of those combined 10 cases the Directors have offered, or agreed to re-pay, the full amount of the mis-appropriated BBL. This is encouraging progress as the Manolete team have only had access to these cases for a few weeks.

 

The Company is now in advanced discussions with another major UK high street bank regarding running a separate BBL recovery pilot programme for that institution.

 

While still at a relatively early stage, the BBL recovery opportunity is potentially highly significant. The Board are confident that the Company's business model is the best route to optimising recoveries in this important area. Prior to Manolete's involvement, certain banks had only managed to achieve a 0.14% recovery on mis-appropriated BBLs.

 

5. Truck Cartel Cases

 

The judgments on the British Telecom and Royal Mail cases were handed down on 7 February 2023. The Company's retained competition law case value experts (Fideres Partners LLP) have accordingly updated their valuation of Manolete's 22 cases and the Board is satisfied that, subject to audit, the current carrying value in the balance sheet of £13.2m is materially correct. Further non-Manolete truck cartel case judgments are awaited, and the Company's own claims remain stayed at present.

 

6. Court of Appeal Decision

 

Over our 13-year operating history, more than 97% of our 665 completed cases have been resolved and settled before trial. Often the defendants on our cases see the good sense in settling the litigation matter before the case is even issued through the Courts. As we highlighted in our H1 FY23 results, one of the rare (larger) cases that did go to a trial resulted in an equally rare adverse trial decision for the Company. The Company was successful in obtaining permission to appeal, but today the Court of Appeal dismissed Manolete's appeal. While this is disappointing, it is one of the very few that the Company has lost at trial in its 13-year history, an enviable track record in the litigation finance industry. The full write off of the fair value of this case had already been accounted in H1 FY23. The final costs (including adverse costs) consequent to the appeal of c. £750k, relating to this case, will now be written off in H2 FY23 and a line drawn under the matter.

 

7. HSBC £25m Revolving Credit Facility ("RCF")

 

Terms of a revised covenant package relating to the RCF have now agreed with HSBC and credit committee approval has been granted by the bank. The new agreement is currently being documented by both sets of legal teams and completion is expected imminently.

 

Consequent to the Company's strong cash generation in FY23 YTD, the Company has repaid a net £3.5m against the RCF. The Company's current exposure under the RCF is £10.5m, leaving £14.5m unutilised headroom on the facility, at present.

 

8. Trading and Financial Outlook

 

Whilst subject to full audit, after a Profit Before Tax loss of £5.5m for H1 FY23, the Company has reported a strong run of 5 months' consecutive profitability to the end of February 2023. Considering all the factors above (including the costs related to the adverse Court of Appeal decision), the Board expects the PBT loss reported for H1 FY23 to be reduced by a positive pre-tax profit contribution for H2 FY23. The Company will give a further update next month, once the full FY23 trading period has been completed.

Based on many of the factors referred to earlier above, the Board expects the Company's overall profitability to recover strongly for FY24 and beyond.

 

 

Steven Cooklin, Chief Executive Officer, commented:

 

"We are delighted with the way that the Company has driven the resurgence in its business after the two-year artificial suppression of the UK insolvency sector, brought about by the UK Government's reaction to the COVID-19 pandemic. The UK is now experiencing record high levels of insolvencies and that is directly leading to the Company's impressive operating performance. With the persistent macro headwinds of inflation and significantly higher interest rates, the Board expects these favourable trading conditions to persist for the foreseeable future."

 

 

 

For further information please contact:

 

Manolete Partners

Steven Cooklin (Chief Executive Officer)

via Instinctif Partners

Peel Hunt (NOMAD and Sole Broker)

Paul Shackleton

 

+44 (0)20 7418 8900

Instinctif Partners

Tim Linacre

Victoria Hayns

+44 (0)20 7457 2020

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSSOROBUOAAR
Date   Source Headline
18th Apr 20247:00 amRNSTrading and Business Update
26th Feb 20247:00 amRNSAppointment of Nominated Adviser and Broker
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
16th Nov 20237:00 amRNSHalf Year Results
9th Nov 20231:50 pmRNSNOTICE OF HY RESULTS, RETAIL INVESTOR PRESENTATION
25th Oct 20239:32 amRNSPresenting at Proactive One2One Investor Forum
18th Oct 20237:00 amRNSTrading Update
19th Sep 20235:15 pmRNSResult of AGM
1st Aug 202311:33 amRNSUpdate regarding the PACCAR Matter
1st Aug 20237:00 amRNSGrant of Share Options
20th Jul 20237:00 amRNSGrant of Share Options
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20234:57 pmRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSThird Year: Band 1 Insolvency Litigation Funding
22nd Jun 20237:00 amRNSAudited results for the year ended 31 March 2023
13th Jun 202310:30 amRNSInvestor Presentation via Investor Meet Company
13th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSBlock Listing Six Monthly Return
22nd May 20237:00 amRNSRetail Investor Presentation at Mello2023
20th Apr 202312:30 pmRNSCORRECTION Further Trading Update
20th Apr 20237:00 amRNSFurther Trading Update
14th Mar 20231:49 pmRNSTrading Update
6th Feb 20237:00 amRNSHire of Former Government Counter-Fraud Expert
21st Dec 20229:11 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSBlock listing Six Monthly Return
10th Nov 20227:00 amRNSHalf Year Results
3rd Nov 20227:00 amRNSNotice of HY Results, Retail Investor Presentation
23rd Sep 20222:37 pmRNSUpdate on case
20th Sep 20222:00 pmRNSResult of AGM
9th Sep 20227:00 amRNSH1 Trading Update
1st Aug 202210:29 amRNSTotal Voting Rights
1st Aug 20227:00 amRNSGrant of Share Options and deferred bonus award
5th Jul 20225:04 pmRNSNotice of AGM
1st Jul 20227:00 amRNSBand 1 Ranking for Insolvency Litigation Funding
23rd Jun 20227:01 amRNSDirectorate Change
23rd Jun 20227:00 amRNSAudited results for the year ended 31 March 2022
16th Jun 20227:00 amRNSRetail Investor Presentation
15th Jun 20227:00 amRNSNotice of Results
1st Jun 20227:00 amRNSBlock Listing Six Monthly Return
3rd May 20227:00 amRNSTotal Voting Rights
26th Apr 20227:00 amRNSUpdate to recent Trading Statement & cash receipt
11th Apr 20227:00 amRNSTrading and business update
1st Mar 20227:00 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSAppointment of Independent Non-Executive Director
4th Jan 20223:34 pmRNSTotal Voting Rights
3rd Dec 20217:00 amRNSGrant of Share Options
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 202111:03 amRNSDirector/PDMR Dealings
26th Nov 202112:52 pmRNSBlock Listing Application
11th Nov 20217:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.